PMID- 1968330
OWN - NLM
STAT- MEDLINE
DCOM- 19900326
LR  - 20190717
IS  - 0003-990X (Print)
IS  - 0003-990X (Linking)
VI  - 47
IP  - 3
DP  - 1990 Mar
TI  - Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.
PG  - 288-9
FAU - Grob, C
AU  - Grob C
FAU - Bravo, G
AU  - Bravo G
FAU - Walsh, R
AU  - Walsh R
LA  - eng
PT  - Clinical Trial
PT  - Comment
PT  - Letter
PL  - United States
TA  - Arch Gen Psychiatry
JT  - Archives of general psychiatry
JID - 0372435
RN  - 0 (Amphetamines)
RN  - 0 (Designer Drugs)
RN  - 4764-17-4 (3,4-Methylenedioxyamphetamine)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
CON - Arch Gen Psychiatry. 1989 Jan;46(1):20-2. PMID: 2562914
MH  - 3,4-Methylenedioxyamphetamine/analogs & derivatives/therapeutic use/*toxicity
MH  - Amphetamines/*toxicity
MH  - Animals
MH  - Clinical Trials as Topic
MH  - Designer Drugs/*toxicity
MH  - Humans
MH  - Mental Disorders/drug therapy
MH  - N-Methyl-3,4-methylenedioxyamphetamine
MH  - Nervous System Diseases/*chemically induced
MH  - Rats
MH  - Research Design/standards
MH  - Substance-Related Disorders/complications
EDAT- 1990/03/01 00:00
MHDA- 1990/03/01 00:01
CRDT- 1990/03/01 00:00
PHST- 1990/03/01 00:00 [pubmed]
PHST- 1990/03/01 00:01 [medline]
PHST- 1990/03/01 00:00 [entrez]
AID - 10.1001/archpsyc.1990.01810150088014 [doi]
PST - ppublish
SO  - Arch Gen Psychiatry. 1990 Mar;47(3):288-9. doi: 
      10.1001/archpsyc.1990.01810150088014.